Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Janover Reports Second Quarter 2024 Financial Results and Provides Business Update
-
Shimmick Corporation Announces Updated Second Quarter 2024 Earnings Conference Call Date
-
Barfresh Announces Non-Recourse Non-Dilutive Litigation Financing
-
Crescent Innovations reports strong interest in asset sale
-
Kane Biotech Receives Funding Support to Expand the revyve™ Antimicrobial Wound Gel Family
-
Pike County Sheriff's Office Conducting First-Ever Online Foreclosure Sales with Bid4Assets.com
-
Renexxion Ireland Ltd. and Dr. Falk Pharma GmbH Announce Expansion of the Phase 2b MOVE-IT Study of Naronapride in Gastroparesis and Dosing of the First United States Patient
-
Lexicon Pharmaceuticals Announces Strategic Repositioning to Drive Value and Growth of Commercial Portfolio
-
Intelligent Bio Solutions Inc. Highlights Growing Need for Drug Testing Solutions in Key Industries
-
Amprius Technologies to Present at the 2024 Gateway Conference on September 4th
-
Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization
-
OMNIQ Schedules Second-Quarter 2024 Earnings Call
-
ConnectM Ranks No. 104 on the Inc. 5000
-
Pike County Sheriff's Office Conducting First-Ever Online Foreclosure Sales with Bid4Assets.com
-
Saratoga Investment Corp. Announces Distribution of Proxy Materials for its 2024 Annual Meeting of Stockholders
-
Montana Technologies to Restate Previously Issued Financial Statements
-
Sabert Fortifies Position as Leading Domestic Manufacturer of Molded Pulp Foodservice Packaging Solutions with Texas Facility BPI Certification
-
Ocean Drive Plastic Surgery Introduces Revolutionary Internal Sports Bra Procedure for Athletes and Fitness Enthusiasts
-
Visa Announces She’s Next Grant Recipients, Spotlighting the Future of Women Entrepreneurs
-
NAPC Defense, Inc. (OTCPK: BLIS) updates Progress with Saudi Arabia regarding Future Plans and CornerShot Demonstrations
-
Bitcoin Depot Reports Second Quarter 2024 Financial Results
-
Palisade Bio Reports Second Quarter 2024 Financial Results and Provides Business Update
-
COSCIENS Biopharma Inc. Reports Second Quarter 2024 Financial Results
-
PodcastOne (Nasdaq: PODC) Reports Q1 FY 2025 Record Revenue of $13.2M (+25% YoY)
-
LiveOne (Nasdaq: LVO) Reports Q1 Fiscal 2025 Revenue of $33.1M
-
SASE vendor Cloudbrink recognized in the 2024 Gartner® Cool Vendors™ in Enabling Efficient Cloud Operations Report
-
NowVertical Group Announces Second Quarter 2024 Earnings Release Date and Financial Update Webinar and Engagement of Investor Relations Service Provider
-
Churchill Resources Identifies New Nickel Targets at the Taylor Brook Project Newfoundland & Labrador
-
Studio City International Holdings Limited Announces Unaudited Second Quarter 2024 Earnings
-
Melco Announces Unaudited Second Quarter 2024 Earnings
-
Mereo BioPharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update
-
Evoke Pharma, Inc. Reports Second Quarter 2024 Financial Results
-
Replimune Announces First Patient Dosed in IGNYTE-3 Clinical Trial in Advanced Melanoma
-
Theriva™ Biologics Reports Second Quarter 2024 Operational Highlights and Financial Results
-
Noema Pharma Announces Completion of Enrollment for GALENE Phase 2B Trial Evaluating NOE-101, a First-in-Class mGluR5 NAM, for Seizure Control in Tuberous Sclerosis Complex
-
Komprise Achieves Inc. 5000 Ranking for Third Year Running
-
Artelo Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update
-
Metatron Announces QuantumBeam – A Revolution in AI-Controlled Energy Transmission
-
High Bar Brands adds VP, restructures sales leadership
-
Linarc Impress Judges and Nets a Win in the 2024 SaaS Awards
-
Daré Bioscience Announces Publication in The Journal of Sexual Medicine of Positive Findings from the Phase 2b RESPOND Clinical Study of Sildenafil Cream, 3.6%
-
Microchip and Acacia Collaborate to Enable Optimized Terabit-Scale Data Center Interconnect Systems
-
Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2024 and Provides Business Update
-
Nuwellis, Inc. Announces Second Quarter 2024 Financial Results
-
BuzzRx® Selects QuestionPro to Enhance Research and Customer Experience Programs
-
Tonix Pharmaceuticals to Present at the Summer 2024 Virtual Investor Summit
-
Biomed Valley Discoveries Announces First Patient Dosed in Phase 2 Study of Its First-in-Class ERK 1/2 Inhibitor Ulixertinib in People with Histiocytosis
-
Acres and LandLeader Forge Partnership to Advance Transparency & Expediency in Rural Land Transactions
-
Ocuphire Pharma Announces Financial Results for Second Quarter 2024 and Provides Corporate Update
-
Gain New Skills While Earning Extra Income as a Seasonal Tax Pro with H&R Block
